NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

47 hedge funds and large institutions have $36.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

91% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 11

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$147K
Puts
$119K
Net Calls
Net Calls Change

Top Buyers

1
+$284K
2
+$271K
3
+$247K
4
JAMONY
Jacob Asset Management of New York
California
+$224K
5
TAM
Tocqueville Asset Management
New York
+$163K

Top Sellers

1
-$695K
2
-$527K
3
-$389K
4
Two Sigma Investments
Two Sigma Investments
New York
-$358K
5
First Trust Advisors
First Trust Advisors
Illinois
-$350K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$182K
27
$162K
28
$117K
29
$102K
30
$97K
31
$76K
32
$73K
33
$72K
34
$37K
35
$23K
36
$19K
37
$16K
38
$12K
39
$5K
40
$3K
41
$2K
42
$2K
43
$1K
44
$1K
45
$1K
46
$1K
47
–
48
–
49
–
50
–
1
2
3